Subsensitivity to bronchoprotection against adenosine monophosphate challenge following regular once-daily formoterol

European Respiratory Journal

Volumn 12, Issue 3, 1998, Pages 580-584

  Aziz, I ^a   Tan, K S ^a   Hall, I P ^b   Devlin, M M ^a   Lipworth, B J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Adenosine monophosphate; Formoterol; Once daily; Subsensitivity

Indexed keywords

ADENOSINE PHOSPHATE; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; FORMOTEROL FUMARATE; IPRATROPIUM BROMIDE; PLACEBO; STEROID;

ADULT; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG SENSITIVITY; DRY POWDER; FEMALE; FORCED EXPIRATORY VOLUME; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NEBULIZER; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; RECEPTOR DENSITY; SPIROMETRY; STATISTICAL ANALYSIS; TACHYPHYLAXIS;

ADENOSINE MONOPHOSPHATE; ADMINISTRATION, ORAL; ADRENERGIC BETA-AGONISTS; ADULT; ASTHMA; BRONCHI; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; CONFIDENCE INTERVALS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG TOLERANCE; ETHANOLAMINES; FEMALE; FORCED EXPIRATORY VOLUME; GENOTYPE; HUMANS; MALE; POLYMERASE CHAIN REACTION; RECEPTORS, ADRENERGIC, BETA; TREATMENT OUTCOME;

EID: 0031663235     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.98.12030580     Document Type: Article

References (17)

1. Grove A, Lipworth BJ. Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patients. Lancet 1995; 346: 201-206.
2. Yates DH, Sussman HS, Shaw MJ, Barnes PJ, Chung KF. Regular formoterol treatment in mild asthma: effect on bronchial responsiveness during and after treatment. Am J Respir Crit Care Med 1995; 152: 1170-1174.
3. Cheung D, Timmers MC, Zwinderman AH, Bel EH, Dijkman JH, Sterk PJ. Long term effects of long-acting beta-2 adrenoceptor agonist salmeterol on airway hyperresponsiveness in patients with mild asthma. N Engl J Med 1992; 327: 1198-1203.
4. Booth H, Bish R, Walters J, Whitehead F, Walters EH. Salmeterol tachyphylaxis in steroid treated asthmatic subjects. Thorax 1996; 51: 1100-1104.
5. Ramage L, Lipworth BJ, Ingram CG, Cree IA, Dhillon DP. Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol. Respir Med 1994; 88: 363-368.
6. Giannini D, Carletti A, Dente FL, et al. Tolerance to the protective effect of salmeterol on allergen challenge. Chest 1996; 110: 1452-1457.
7. Kalra S, Swystun VA, Bhagat R, Cockcroft DW. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol. Chest 1996; 109: 953-956.
8. Rabe KF, Jorres R, Novak D, Behr N, Magnussen H. Comparison of the effects of salmeterol and formoterol on airway tone and responsiveness over 24 hours in bronchial asthma. Am Rev Respir Dis 1993; 147: 1436-1441.
9. British Thoracic Society. Guidelines on the management of asthma. Thorax 1997; 52: S1-S21.
10. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136: 225-244.
11. American Thoracic Society. Standardisation ot spirometery - update. Am Rev Respir Dis 1987; 136: 1285-1298.
12. Chinn S. Repeatability and method comparison. Thorax 1991; 46: 454-456.
13. 2-adrenoceptor polymorphism with lower airways reactivity in asthmatic subjects. Lancet 1995; 345: 1213-1214.
14. Newnham DM, Grove A, McDevitt DG, Lipworth BJ. Subsensitivity of bronchodilator and systemic beta-2 adrenoceptor responses after regular twice daily treatment with formoterol dry powder in asthmatic patients. Thorax 1995; 50: 497-504.
15. Egbagbe E, Pavord ID, Wilding P, Thompson-Coon J, Tattersfield AE. Adenosine monophosphate and histamine induced bronchoconstriction: repeatability and protection by terbutaline. Thorax 1997; 52: 239-243.
16. 2-agonists in asthma. N Engl J Med 1992; 327: 1204-1208.
17. 2-adrenoceptor polymorphisms: are they clinically important. Thorax 1996; 51: 351-353.